We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$16.8B
AUM Growth
+$2.43B
(+17%)
Cap. Flow
+$2.2B
Cap. Flow
% of AUM
13.07%
Top 10 Holdings %
Top 10 Hldgs %
12.03%
Holding
1,764
New
564
Increased
341
Reduced
326
Closed
526
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.58% |
| 3 | Consumer Staples | 7.89% |
| 4 | Financials | 7.87% |
| 5 | Healthcare | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LLL
251
DELISTED
L3 Technologies, Inc.
LLL
| $20M | 0.12% |
169,129
+141,517
| +513% | +$16.5M |
|
252
G-III Apparel Group
GIII
$1.5B
| $20M | 0.12% |
+409,682
| New | +$19.8M |
|
|
LNKD
253
DELISTED
LinkedIn Corporation
LNKD
| $20M | 0.12% |
175,000
-212,198
| -55% | -$31.2M |
|
254
Take-Two Interactive
TTWO
$46.1B
| $19.9M | 0.12% |
528,675
+446,809
| +546% | +$15.5M |
|
|
LTRPA
255
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $19.7M | 0.12% |
889,855
+875,325
| +6,024% | +$19.2M |
|
256
CALL
HCA Healthcare
HCA
$89.5B
| $19.5M | 0.12% |
+250,000
| New | +$17.5M |
|
|
N
257
DELISTED
Netsuite Inc
N
| $19.4M | 0.12% |
283,160
+198,985
| +236% | +$13M |
|
258
Abbott
ABT
$187B
| $19.4M | 0.12% |
+463,047
| New | +$18.3M |
|
259
Sensata Technologies
ST
$6.79B
| $19.1M | 0.11% |
492,121
+472,121
| +2,361% | +$17.1M |
|
260
Chubb
CB
$135B
| $19M | 0.11% |
159,463
-302,327
| -65% | -$34.7M |
|
261
CALL
Regions Financial
RF
$26.8B
| $18.8M | 0.11% |
2,400,000
+1,450,000
| +153% | +$11.7M |
|
|
VSTO
262
DELISTED
Vista Outdoor Inc.
VSTO
| $18.7M | 0.11% |
+360,323
| New | +$17.4M |
|
|
SPN
263
DELISTED
Superior Energy Services, Inc.
SPN
| $18.3M | 0.11% |
136,910
+135,725
| +11,454% | +$14.8M |
|
264
Thermo Fisher Scientific
TMO
$220B
| $18.3M | 0.11% |
128,985
+27,212
| +27% | +$3.65M |
|
|
SGI
265
CALL
Somnigroup International
SGI
$13.7B
| $18.2M | 0.11% |
+1,200,000
| New | +$17.8M |
|
|
266
CALL
Teva Pharmaceuticals
TEVA
$41.2B
| $18.2M | 0.11% |
+340,000
| New | +$19.9M |
|
|
SEE
267
DELISTED
Sealed Air
SEE
| $18.1M | 0.11% |
+377,231
| New | +$16.5M |
|
268
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $18.1M | 0.11% |
+350,000
| New | +$18.2M |
|
269
Labcorp
LH
$25.9B
| $18M | 0.11% |
+179,000
| New | +$17.2M |
|
270
Brown & Brown
BRO
$23.9B
| $18M | 0.11% |
1,003,410
+684,800
| +215% | +$11M |
|
271
Antero Resources
AR
$10.7B
| $17.9M | 0.11% |
+721,093
| New | +$17.3M |
|
272
PUT
Exelon
EXC
$47B
| $17.9M | 0.11% |
+701,000
| New | +$15.7M |
|
|
MRO
273
DELISTED
Marathon Oil Corporation
MRO
| $17.8M | 0.11% |
+1,597,748
| New | +$14.9M |
|
|
XLNX
274
CALL
DELISTED
Xilinx Inc
XLNX
| $17.8M | 0.11% |
375,000
+325,000
| +650% | +$15.3M |
|
275
Tenet Healthcare
THC
$21.1B
| $17.8M | 0.11% |
614,468
+281,048
| +84% | +$7.31M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Balyasny Asset Management held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Balyasny Asset Management deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Balyasny Asset Management's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Balyasny Asset Management added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Balyasny Asset Management's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Balyasny Asset Management fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Balyasny Asset Management's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Balyasny Asset Management opened 564 new positions and closed 526 in Q1 2016.
- Balyasny Asset Management's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.